San Jose, CA, United States of America

Marcus Wong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sumitomo Dainippon Pharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcus Wong. Retrieved from https://idiyas.com/inventor/marcus-wong-b0s4jzzg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Marcus Wong

Introduction

Marcus Wong is an accomplished inventor based in San Jose, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of vaccine adjuvants. His work focuses on enhancing the efficacy of vaccines through innovative compounds.

Latest Patents

Marcus Wong holds a patent for adenine conjugate compounds and their use as vaccine adjuvants. The patent describes adenine conjugate compounds represented by a specific formula, which possess immunostimulating properties. These compounds may be beneficial in therapeutic applications, particularly as vaccine adjuvants. The patent also outlines a process for preparing these compounds and their pharmaceutically acceptable salts, along with pharmaceutical compositions that include them.

Career Highlights

Marcus Wong is currently employed at Sumitomo Dainippon Pharma Co., Ltd. His work at this esteemed company has allowed him to focus on innovative research and development in the pharmaceutical industry. His contributions have the potential to impact vaccine development significantly.

Collaborations

Throughout his career, Marcus Wong has collaborated with notable colleagues, including Hitoshi Ban and Yukihiro Nishio. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Marcus Wong's work in developing adenine conjugate compounds showcases his dedication to advancing vaccine technology. His innovative approach and collaboration with esteemed colleagues position him as a key figure in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…